| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Revenue | $189.9M | -13.5% |
| Cost of Revenue | $89.9M | -25.3% |
| Gross Profit | $100.0M | +0.6% |
| R&D Expense | $101.6M | -50.5% |
| SG&A Expense | $113.3M | -12.7% |
| Operating Income | -$240.6M | +64.7% |
| Income Tax | -$41K | -156.2% |
| Net Income | -$280.9M | +57.9% |
| EPS (Basic) | -$10.88 | +61.2% |
| EPS (Diluted) | -$10.88 | +61.2% |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $38.2M | -82.3% |
| Accounts Receivable | $1.4M | -59.3% |
| Inventory | $15.6M | +24.8% |
| Current Assets | $102.7M | -59.8% |
| Total Assets | $159.9M | -59.5% |
| Current Liabilities | $72.7M | -42.9% |
| Total Liabilities | $186.6M | -9.7% |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$169.6M | -3.2% |
| Capital Expenditures | $869K | -23.0% |
| Investing Cash Flow | -$3.7M | +61.5% |
| Financing Cash Flow | -$279K | -107.8% |
| Free Cash Flow | -$170.5M | -3.0% |
| Stockholders' Equity |
| -$26.7M |
| -114.2% |